Recro Pharma Inc

NASDAQ:REPH   3:59:37 PM EDT
2.39
+0.07 (+3.02%)
Earnings Announcements

Recro Pharma Reports Third Quarter 2020 Financial Results

Published: 11/09/2020 12:39 GMT
Recro Pharma Inc (REPH) - Recro Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.09.
Q3 Revenue $19.3 Million.
Revenue is expected to be $16.31 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $18.87 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.